Search

everythinglearnresearchcommunity

for

Search:↓

People with alopecia areata may be more likely to have a certain type of hearing loss.

CT60 polymorphism might increase the risk of Alopecia Areata.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Sardinians were historically short due to a mix of genetics and factors like disease and poor nutrition, but recent height increases suggest better living conditions had a bigger impact.

The 60-second timed hair count is a reliable and simple way to measure hair shedding at home, showing older women tend to shed more hair than younger women.

Cyclosporin doesn't stop hair loss.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

Early detection and stopping the drug are key to managing DRESS, and careful monitoring is important due to possible severe reactions.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

The book details skin conditions in older adults, their link to mental health, cancer treatment importance, hair loss remedies, and managing autoimmune and itchy skin.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

Pregnancy can cause unique skin issues, some of which may risk the mother and baby's health and need careful treatment.

Topical treatments led to hair regrowth in a man with linear morphea.

The document concludes that immune system abnormalities cause alopecia areata, but the exact process is still not completely understood.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Blocking the ATX-LPA pathway may improve insulin sensitivity and mitochondrial function in obesity.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Regenerative cellular therapies show promise for treating non-scarring hair loss but need more research.

Umbilical cord blood is a valuable source of stem cells for medical treatments, but its use is less common than other transplants, and there are ethical issues to consider.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Both HLA-B and MICA are independently linked to alopecia areata.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Alopecia areata causes hair loss due to an immune attack on hair follicles, influenced by genetics and environment.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.